Abstract:Abstract Metastasis is a major factor in treatment failure in patients with pancreatic cancer, but the underlying mechanisms remain unclear, and new, effective treatment strategies are needed. Here, we sought to identify novel microRNAs (miRNAs) with a key role in pancreatic cancer metastasis. Using a microarray analysis to evaluate miRNA expression in metastatic and non-metastatic pancreatic cancer, we found that expression of the miRNA, hsa-miR-6794-3p, was significantly lower in metastatic pancreatic cancer tissues than in non-metastatic pancreatic cancer tissues. Methylation-specific polymerase chain reaction analyses revealed that hsa-miR-6794-3p expression was downregulated in metastatic pancreatic cancer cells by hypermethylation of CpG islands within the hsa-miR-6794-3p promoter. Gain- and loss-of-function approaches using the human pancreatic cancer cell lines, MIA-PaCa-2 and HPAF-II, expressing low and high levels of hsa-miR-6794-3p, respectively, suggested a role for hsa-miR-6794-3p in decreasing cell invasion, migration, and epithelial-mesenchymal transition (EMT) signaling. Notably, we found that hsa-miR-6794-3p exerts its effects by inhibiting expression of the chromatin remodeling factor, RBBP4, through direct binding to the 3’-untranslated region of its mRNA. The resulting suppression of RBBP4 expression increases levels of the transcription factor GRHL2, which is involved in regulating invasion, migration, and EMT signaling in metastatic pancreatic cancer cells. Thus, lower levels of hsa-miR-6794-3p disrupt GRHL2-mediated regulation of these pathways by disinhibiting expression of the GRHL2 negative regulator, RBBP4. Consistent with these findings, an investigation of the relationship between hsa-miR-6794-3p and clinicopathological features in pancreatic cancer patients using publicly available datasets and immunohistochemistry showed that low levels of hsa-miR-6794-3p are correlated with a poorer prognosis in pancreatic cancer patients. Additional preclinical experiments in nude mice clearly demonstrated that hsa-miR-6794-3p is capable of suppressing pancreatic cancer cell metastasis. Taken together, these results suggest that hsa-miR-6794-3p suppresses tumor metastasis and thus represents a promising prognostic biomarker and therapeutic target in pancreatic cancer. Citation Format: Ha Gyeong Kim, Eun-Taex Oh, Yunmi Cho, Heon Joo Park. Identification of hsa-miR-6794-3p as a key regulatory factor in human pancreatic cancer metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 455.

Identification of miR-6794-3p as a suppressor in pancreatic cancer metastasis

MicroRNA-204-3p Inhibits Metastasis of Pancreatic Cancer Via Downregulating MGAT1.

Abstract 455: Identification of hsa-miR-6794-3p as a key regulatory factor in human pancreatic cancer metastasis

Retracted: Mir‐944 Inhibits Metastasis of Gastric Cancer by Preventing the Epithelial–mesenchymal Transition Via MACC1/Met/AKT Signaling

MicroRNA-494 Regulates Gli3 Expression and Inhibits Pancreatic Cancer Cells Growth and Migration

MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.

Mir‑448 Targets Rab2B and is Pivotal in the Suppression of Pancreatic Cancer

MiR-489-3p Reduced Pancreatic Cancer Proliferation and Metastasis by Targeting PKM2 and LDHA Involving Glycolysis

MicroRNA-323-3 P Inhibits Cell Invasion and Metastasis in Pancreatic Ductal Adenocarcinoma Via Direct Suppression of SMAD 2 and SMAD 3

miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway

MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.

MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3

Microrna-375 Is Downregulated In Pancreatic Cancer And Inhibits Cell Proliferation In Vitro

MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer Through Targeting CAB39.

MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells

MiR-216b Inhibits Pancreatic Cancer Cell Progression and Promotes Apoptosis by Down-Regulating KRAS

Mirna-339-5p Plays an Important Role in Invasion and Migration of Pancreatic Cancer Cells

Retracted: Microrna-4656 Is A Prognostic Factor And Tumor Suppressor In Human Pancreatic Cancer Through A Downstream Target Of Trka (Retracted Article. See Vol 19, Artn E2967, 2017)

Expression of microR-144-3p in pancreatic cancer and its effect on migration and invasion of pancreatic cancer cells

Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis

miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma.